Intuitive Surgical, Inc.: Expansion of da Vinci 5 (dV5) Products & Services

Intuitive Surgical experienced healthy performance in the second quarter of 2024, with strong capital placements and solid procedure growth. Several advancements were made, with the rollout of da Vinci 5, stability of Ion supply, and expanding da Vinci SP installs in Europe among the highlights. The company also faced some headwinds related to multiport procedures. In terms of systems, there was significant growth in procedure counts for the quarter, nearly 17% when compared to second quarter 2023. There were also 341 da Vinci systems placed, 74 Ion systems, and 21 SP systems in the quarter, indicating increased demand for robotic and minimally invasive solutions in surgical procedures. This was observed across multiple regions, from the U.S to Japan and India, although there were some pressures in Europe and China.